Board Director of CICC and GM of Ponzini Health and Beauty High-Tech (Suzhou) Co., Ltd.

Kent D. Kedl is a Partner and head of Control Risks’ Greater China and North Asia practice. He is responsible for all of Control Risks’ work across mainland China, Hong Kong, Macau, Taiwan, the Koreas and Mongolia. Kent has been living and working in China for more than 35 years.

Kent has consulted with multinational and Asia-based corporations on a range of risk and strategy issues, such as M&A and organic growth strategy, crisis management, compliance, and strategic and organisational development programmes.

Before joining Control Risks, Kent was a partner of Technomic Asia, a market strategy and M&A consulting firm.

Kent has worked as a journalist and is a frequent contributor to Asia-based media outlets. Kent has a bachelor’s degree in English and a master’s degree in East Asian studies from the University of Minnesota. He also completed graduate studies in journalism and mass communication at the China Times Centre for Mass Media and Social Studies.

Currently in the role of Aptar China President and also responsible for Aptar Pharma NEA Region (Northeast Asia, i.e. Japan, South Korea & Greater China).
20+ years experience in the healthcare industry, B2B
Roles in general management and commercial